Background: Biomarkers play critical roles in early detection, diagnosis and monitoring of therapeutic outcome and recurrence of cancer. Previous biomarker research on ovarian cancer (OC) has mostly focused on the discovery and validation of diagnostic biomarkers. The primary purpose of this study is to identify serum biomarkers for prognosis and therapeutic outcomes of ovarian cancer. Experimental Design: Forty serum proteins were analyzed in 70 serum samples from healthy controls (HC) and 101 serum samples from serous OC patients at three different disease phases: post diagnosis (PD), remission (RM) and recurrence (RC). The utility of serum proteins as OC biomarkers was evaluated using a variety of statistical methods including surviva...
BACKGROUND: Ovarian cancer is the eighth most common cancer among women and has a 5-year survival of...
BACKGROUND: CA125 is the best available yet insufficiently sensitive biomarker for early detection o...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
BACKGROUND: Biomarkers play critical roles in early detection, diagnosis and monitoring of therapeut...
<div><p>Background</p><p>Biomarkers play critical roles in early detection, diagnosis and monitoring...
Early detection remains the most promising approach to improve long-term survival of patients with o...
We set out to discover ovarian cancer biomarkers useful for monitoring progression during and after ...
In Canada, ovarian cancer is the third most common female reproductive cancer and the leading cause ...
Ovarian cancer is the fifth leading cause of cancer death in women in the U.S. Currently, two serum ...
FDA-cleared ovarian cancer biomarkers are limited to CA-125 and HE4 for monitoring and recurrence an...
High-grade serous ovarian cancer (HGSOC) represents the major histological type of ovarian cancer, a...
Epithelial ovarian cancer is the fourth leading cause of cancer death among women. Due to the asympt...
Background Ovarian cancer is the eighth most common cancer among women and due to late detection pro...
Background: CA125 is the best available yet insufficiently sensitive biomarker for early detection o...
We used intensive modern proteomics approaches to identify predictive proteins in ovary cancer. We i...
BACKGROUND: Ovarian cancer is the eighth most common cancer among women and has a 5-year survival of...
BACKGROUND: CA125 is the best available yet insufficiently sensitive biomarker for early detection o...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
BACKGROUND: Biomarkers play critical roles in early detection, diagnosis and monitoring of therapeut...
<div><p>Background</p><p>Biomarkers play critical roles in early detection, diagnosis and monitoring...
Early detection remains the most promising approach to improve long-term survival of patients with o...
We set out to discover ovarian cancer biomarkers useful for monitoring progression during and after ...
In Canada, ovarian cancer is the third most common female reproductive cancer and the leading cause ...
Ovarian cancer is the fifth leading cause of cancer death in women in the U.S. Currently, two serum ...
FDA-cleared ovarian cancer biomarkers are limited to CA-125 and HE4 for monitoring and recurrence an...
High-grade serous ovarian cancer (HGSOC) represents the major histological type of ovarian cancer, a...
Epithelial ovarian cancer is the fourth leading cause of cancer death among women. Due to the asympt...
Background Ovarian cancer is the eighth most common cancer among women and due to late detection pro...
Background: CA125 is the best available yet insufficiently sensitive biomarker for early detection o...
We used intensive modern proteomics approaches to identify predictive proteins in ovary cancer. We i...
BACKGROUND: Ovarian cancer is the eighth most common cancer among women and has a 5-year survival of...
BACKGROUND: CA125 is the best available yet insufficiently sensitive biomarker for early detection o...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...